for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Pulike Biological Engineering Inc

603566.SS

Latest Trade

19.33CNY

Change

0.57(+3.04%)

Volume

5,059,628

Today's Range

18.53

 - 

19.89

52 Week Range

11.33

 - 

25.30

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
18.76
Open
18.92
Volume
5,059,628
3M AVG Volume
77.98
Today's High
19.89
Today's Low
18.53
52 Week High
25.30
52 Week Low
11.33
Shares Out (MIL)
321.50
Market Cap (MIL)
6,214.52
Forward P/E
48.73
Dividend (Yield %)
1.55

Latest Developments

More

Pulike Biological Engineering sets up veterinary drug and animal health products related JV in Yunnan

Pulike Biological Engineering to sign technology development contract worth 10 mln yuan

Pulike Biological Engineering to pay A shares div for FY 2017 on June 5

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Pulike Biological Engineering Inc

Pulike Biological Engineering. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The Company's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.

Industry

Biotechnology & Drugs

Contact Info

No. 15, Zhenghe Road, Luolong District

+86.379.63282386

http://www.pulike.com.cn/

Executive Leadership

Xuke Zhang

Chairman of the Board

Jinzhong Sun

Vice Chairman of the Board

Lianfeng Pei

Chief Financial Officer

Dechao Qin

General Manager

Wei Hu

Deputy General Manager, Director

Key Stats

1.29 mean rating - 7 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

0.6K

2018

0.6K

2019(E)

0.6K
EPS (CNY)

2016

0.590

2018

0.419

2019(E)

0.397
Price To Earnings (TTM)
55.79
Price To Sales (TTM)
9.59
Price To Book (MRQ)
3.80
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
6.73
Return on Equity (TTM)
6.05

Latest News

Latest News

BRIEF-Pulike Biological Engineering to set up veterinary drugs JV in Yunnan

* Says it plans to invest 162.8 million yuan to set up a JV, which will be mainly engaged in veterinary drug and animal health products related business, with registered capital of 350 million yuan, with partners, in Yunnan

BRIEF-Pulike Biological Engineering obtains high-tech enterprise recognition

* Says it and unit will enjoy tax preference of 15 percent for three years from Dec. 22

BRIEF-Pulike Biological Engineering receives subsidy worth 12.7 mln yuan from government

* Says it receives subsidy worth 12.7 million yuan from government

BRIEF-Pulike Biological Engineering to pay FY 2016 annual div on June 5

Pulike Biological Engineering Inc : * Says it plans to pay FY 2016 annual div on June 5 Source text in Chinese: https://goo.gl/M4mITr Further company coverage: (Beijing Headline News)

BRIEF-Pulike Biological Engineering's board elects chairman, vice chairman

* Says board elects Zhang Xuke as chairman, Sun Jinzhong as vice chairman

BRIEF-Pulike Biological Engineering to pay cash 2 yuan per 10 shares as FY 2016 div payment

* Says it plans to pay cash 2 yuan per 10 shares as FY 2016 div payment

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up